Baroreflex sensitivity changes with calcium antagonist therapy in elderly subjects with isolated systolic hypertension

Abstract

In order to study the effects of calcium-blocking therapy on cardiovascular homeostasis in elderly subjects with isolated systolic hypertension, we performed a randomised double-blind placebo-controlled crossover study of 6 weeks therapy with modified-release nifedipine or placebo. Changes with calcium-blocker treatment in clinic and 24-h blood pressure (BP), heart rate, BP variability, baroreflex sensitivity (BRS) by three methods (Valsalva manoeuvre, phenylephrine and sodium nitroprusside injection), and in baroreflex- and non-baroreflex-mediated reflexes (tilt and cold face stimulus) were studied in 14 elderly subjects (mean age [± SEM] 70 ± 1 years) with sustained isolated systolic hypertension (clinic BP 179 ± 3/85 ± 1 mm Hg). Clinic systolic BP, but not diastolic BP, was reduced with treatment (by 14 ± 6 mm Hg, P = 0.03, diastolic BP 4 ± 3 mm Hg, P = 0.16). Twenty-four hour BP was also reduced by nifedipine treatment (by 18 ± 3/9 ± 2 mm Hg, both P < 0.001). clinic and 24-h heart rate, and daytime bp variability, were unchanged with treatment. brs was significantly increased during nifedipine therapy by all three measurement methods (all P < 0.05). with 60° tilt during active treatment, subjects exhibited a greater heart rate increase (P < 0.01), and a reduced fall in systolic (P < 0.05) and diastolic bp (P < 0.05). thus despite the arteriosclerosis and reductions in large artery compliance described in elderly patients with isolated systolic hypertension, clinically important improvements in clinic and ambulatory bp and some aspects of cardiovascular homeostasis can be achieved with calcium-channel blocking therapy.